V025-2609 Screening compound: 3-[5-amino-3-(4-methoxyphenyl)-1-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl]-1-(cyclohexylmethyl)urea

V025-2609 Screening compound: 3-[5-amino-3-(4-methoxyphenyl)-1-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl]-1-(cyclohexylmethyl)urea
V025-2609 Screening compound: 3-[5-amino-3-(4-methoxyphenyl)-1-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl]-1-(cyclohexylmethyl)urea alternative view

Chemical Structure Depiction of ChemDiv screening compound V025-2609
3-[5-amino-3-(4-methoxyphenyl)-1-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl]-1-(cyclohexylmethyl)urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V025-2609

Molecular Formula

C25H28F3N5O2 (C25 H28 F3 N5 O2)

Compound Name

3-[5-amino-3-(4-methoxyphenyl)-1-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl]-1-(cyclohexylmethyl)urea

IUPAC name

3-[5-amino-3-(4-methoxyphenyl)-1-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl]-1-(cyclohexylmethyl)urea

SMILES

COc(cc1)ccc1-c(c(NC(NCC1CCCCC1)=O)c1N)nn1-c1ccc(C(F)(F)F)cc1

InChI

InChI=1S/C25H28F3N5O2/c1-35-20-13-7-17(8-14-20)21-22(31-24(34)30-15-16-5-3-2-4-6-16)23(29)33(32-21)19-11-9-18(10-12-19)25(26,27)28/h7-14,16H,2-6,15,29H2,1H3,(H2,30,31,34)

InChI Key

BPZKMMVDPVNWLX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14265640

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

487.53

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

4.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.246

Distribution Coefficient, logD

5.246

Water Solubility, LogSw

-5.13

Polar Surface Area

73.795

Acid Dissociation Constant (pKa)

12.92

Base Dissociation Constant (pKb)

-1.37

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.00

V025-2609 in Drug Discovery

Included in Screening Libraries

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • Epigenetic
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with V025-2609 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V025-2609?
Check Price and Availability of V025-2609, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V025-2609 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V025-2609
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V025-2609
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V025-2609 available by request